Literature DB >> 23775232

Transcatheter closure of secundum atrial septal defect.

Hideto Shimpo1, Reina Hojo, Maeshiro Ryo, Takeshi Konuma, Hironori Tempaku.   

Abstract

Since the introduction of transcatheter closure of atrial septal defect, device closure has become the alternative treatment of selected atrial defects. Although excellent results have been reported for transcatheter closure, concerns have arisen regarding complications, including residual shunt, systemic or pulmonary embolization of the device, and erosion and perforation of the cardiac chamber. Those complications are rare but potentially serious adverse events that may require immediate surgical intervention. This review summarizes the current trends in patient selection, result of device closure and typical complications. Comparison between transcatheter device closure and surgical closure is also made.

Entities:  

Mesh:

Year:  2013        PMID: 23775232     DOI: 10.1007/s11748-013-0268-7

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  48 in total

1.  Recent changes in instructions for use for the Amplatzer atrial septal defect occluder: how to incorporate these changes while using transesophageal echocardiography or intracardiac echocardiography?

Authors:  Kiran Mallula; Zahid Amin
Journal:  Pediatr Cardiol       Date:  2012-05-11       Impact factor: 1.655

2.  Repair of aortic-left atrial fistula following the transcatheter closure of an atrial septal defect.

Authors:  Dennis M Mello; John Fahey; Gary S Kopf
Journal:  Ann Thorac Surg       Date:  2005-10       Impact factor: 4.330

3.  Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience.

Authors:  J Masura; P Gavora; A Formanek; Z M Hijazi
Journal:  Cathet Cardiovasc Diagn       Date:  1997-12

4.  Comparison of atrial septal defect closure using amplatzer septal occluder with surgery.

Authors:  K Durongpisitkul; J Soongswang; D Laohaprasitiporn; A Nana; S Sriyoschati; S Ponvilawan; T Subtaweesin; C Kangkagate
Journal:  Pediatr Cardiol       Date:  2002-02-19       Impact factor: 1.655

5.  Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure?

Authors:  P Ewert; F Berger; N Nagdyman; O Kretschmar; S Dittrich; H Abdul-Khaliq; P Lange
Journal:  Catheter Cardiovasc Interv       Date:  2001-02       Impact factor: 2.692

6.  Usefulness of early diastolic mitral annular velocity to predict plasma levels of brain natriuretic peptide and transient heart failure development after device closure of atrial septal defect.

Authors:  Satoshi Masutani; Mio Taketazu; Chihiro Mihara; Yuko Mimura; Hirotaka Ishido; Tamotsu Matsunaga; Toshiki Kobayashi; Hideaki Senzaki
Journal:  Am J Cardiol       Date:  2009-12-15       Impact factor: 2.778

7.  Emergent surgical retrieval of embolized atrial septal defect closure device.

Authors:  Christopher J Knott-Craig; Steven P Goldberg
Journal:  Ann Thorac Surg       Date:  2008-01       Impact factor: 4.330

8.  The 'aortic rim' recount: embolization of interatrial septal occluder into the main pulmonary artery bifurcation after atrial septal defect closure.

Authors:  Manoranjan Misra; Adil Sadiq; Narayanan Namboodiri; Jayakumar Karunakaran
Journal:  Interact Cardiovasc Thorac Surg       Date:  2007-03-15

9.  Community use of the amplatzer atrial septal defect occluder: results of the multicenter MAGIC atrial septal defect study.

Authors:  Allen D Everett; Jacky Jennings; Erica Sibinga; Carl Owada; D Scott Lim; John Cheatham; Ralf Holzer; Jeremy Ringewald; Rani Bandisode; Richard Ringel
Journal:  Pediatr Cardiol       Date:  2008-11-18       Impact factor: 1.655

Review 10.  Transcatheter closure of intracardiac defects in adults.

Authors:  Michael S Kim; Andrew J Klein; John D Carroll
Journal:  J Interv Cardiol       Date:  2007-12       Impact factor: 2.279

View more
  1 in total

1.  Key Regulatory Differentially Expressed Genes in the Blood of Atrial Septal Defect Children Treated With Occlusion Devices.

Authors:  Bo-Ning Li; Quan-Dong Tang; Yan-Lian Tan; Liang Yan; Ling Sun; Wei-Bing Guo; Ming-Yang Qian; Allen Chen; Ying-Jun Luo; Zhou-Xia Zheng; Zhi-Wei Zhang; Hong-Ling Jia; Cong Liu
Journal:  Front Genet       Date:  2021-12-08       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.